Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia
    Journal Article

    Brown, F. C.; Still, E.; Koche, R. P.; Yim, C. Y.; Takao, S.; Cifani, P.; Reed, C.; Gunasekera, S.; Ficarro, S. B.; Romanienko, P.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: Phase 1 results and long-term follow-up
    Journal Article

    Kreitman, R. J.; Tallman, M. S.; Robak, T.; Coutre, S.; Wilson, W. H.; Stetler-Stevenson, M.; FitzGerald, D. J.; Santiago, L.; Gao, G.; Lanasa, M. C.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
    Journal Article

    Stein, E. M.; Garcia-Manero, G.; Rizzieri, D. A.; Tibes, R.; Berdeja, J. G.; Savona, M. R.; Jongen-Lavrenic, M.; Altman, J. K.; Thomson, B.; Blakemore, S. J.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
    Journal Article

    Intlekofer, A. M.; Joffe, E.; Batlevi, C. L.; Hilden, P.; He, J.; Seshan, V. E.; Zelenetz, A. D.; Palomba, M. L.; Moskowitz, C. H.; Portlock, C.; more...
    Blood Cancer Journal (2018)

    Fulltext@MSK | Save
  • A comparison of immune reconstitution following human placenta-derived stem cells (HPDSC) with umbilical cord blood transplantation (UCBT) vs. UCBT alone in pediatric recipients with malignant and non-malignant diseases
    Meeting Abstract

    Sandhu, S.; Flower, A.; Geyer, M.; Harrison, L.; Shi, Q.; Pulsipher, M.; Giller, R.; Morris, E.; Klejmont, L.; Ayello, J.; more...
    Journal of Clinical Immunology (2018)

    Fulltext@MSK | Save
  • Treatment-free remission (TFR) in patients with chronic-phase chronic myeloid leukemia (CML-CP) with stable deep molecular response (DMR) discontinuing dasatinib (DASFREE)
    Meeting Abstract

    Shah, N. P.; Garcia-Gutierrez, J. V.; Jimenez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gomez-Casares, M. T.; Pane, F.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • Efficacy and safety of first-line bosutinib versus imatinib in the BFORE trial: 18-month follow-up
    Meeting Abstract

    Clark, R. E.; Gambacorti-Passerini, C.; Deininger, M.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Dyagil, I.; Glushko, N.; Milojkovic, D.; Le Coutre, P.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML
    Journal Article

    Cusan, M.; Cai, S. F.; Mohammad, H. P.; Krivtsov, A.; Chramiec, A.; Loizou, E.; Witkin, M. D.; Smitheman, K. N.; Tenen, D. G.; Ye, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Do preclinical studies suggest that CD99 is a potential therapeutic target in acute myeloid leukemia and the myelodysplastic syndromes?
    Journal Article

    Tavakkoli, M.; Chung, S. S.; Park, C. Y.
    Expert Opinion on Therapeutic Targets (2018)

    Fulltext@MSK | Save
  • Pretransplant consolidation is not beneficial for adults with ALL undergoing myeloablative allogeneic transplantation
    Journal Article

    Bejanyan, N.; Zhang, M. J.; Wang, H. L.; Lazaryan, A.; de Lima, M.; Marks, D. I.; Sandmaier, B. M.; Bachanova, V.; Rowe, J.; Tallman, M.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save